BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22184063)

  • 1. Vpr-binding protein antagonizes p53-mediated transcription via direct interaction with H3 tail.
    Kim K; Heo K; Choi J; Jackson S; Kim H; Xiong Y; An W
    Mol Cell Biol; 2012 Feb; 32(4):783-96. PubMed ID: 22184063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 Vpr Protein Enhances Proteasomal Degradation of MCM10 DNA Replication Factor through the Cul4-DDB1[VprBP] E3 Ubiquitin Ligase to Induce G2/M Cell Cycle Arrest.
    Romani B; Shaykh Baygloo N; Aghasadeghi MR; Allahbakhshi E
    J Biol Chem; 2015 Jul; 290(28):17380-9. PubMed ID: 26032416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunodeficiency virus type 1 Vpr-binding protein VprBP, a WD40 protein associated with the DDB1-CUL4 E3 ubiquitin ligase, is essential for DNA replication and embryonic development.
    McCall CM; Miliani de Marval PL; Chastain PD; Jackson SC; He YJ; Kotake Y; Cook JG; Xiong Y
    Mol Cell Biol; 2008 Sep; 28(18):5621-33. PubMed ID: 18606781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vpr Targets TET2 for Degradation by CRL4
    Lv L; Wang Q; Xu Y; Tsao LC; Nakagawa T; Guo H; Su L; Xiong Y
    Mol Cell; 2018 Jun; 70(5):961-970.e5. PubMed ID: 29883611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 Vpr increases HCV replication through VprBP in cell culture.
    Yan Y; Huang F; Yuan T; Sun B; Yang R
    Virus Res; 2016 Sep; 223():153-60. PubMed ID: 27460548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation of mobile chromatin-associated nuclear foci containing HIV-1 Vpr and VPRBP is critical for the induction of G2 cell cycle arrest.
    Belzile JP; Abrahamyan LG; Gérard FC; Rougeau N; Cohen EA
    PLoS Pathog; 2010 Sep; 6(9):e1001080. PubMed ID: 20824083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 Vpr-mediated G2 arrest involves the DDB1-CUL4AVPRBP E3 ubiquitin ligase.
    Belzile JP; Duisit G; Rougeau N; Mercier J; Finzi A; Cohen EA
    PLoS Pathog; 2007 Jul; 3(7):e85. PubMed ID: 17630831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining the interactions and role of DCAF1/VPRBP in the DDB1-cullin4A E3 ubiquitin ligase complex engaged by HIV-1 Vpr to induce a G2 cell cycle arrest.
    Gérard FC; Yang R; Romani B; Poisson A; Belzile JP; Rougeau N; Cohen ÉA
    PLoS One; 2014; 9(2):e89195. PubMed ID: 24558487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VprBP has intrinsic kinase activity targeting histone H2A and represses gene transcription.
    Kim K; Kim JM; Kim JS; Choi J; Lee YS; Neamati N; Song JS; Heo K; An W
    Mol Cell; 2013 Nov; 52(3):459-67. PubMed ID: 24140421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 Vpr protein inhibits telomerase activity via the EDD-DDB1-VPRBP E3 ligase complex.
    Wang X; Singh S; Jung HY; Yang G; Jun S; Sastry KJ; Park JI
    J Biol Chem; 2013 May; 288(22):15474-80. PubMed ID: 23612978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lentiviral Vpr usurps Cul4-DDB1[VprBP] E3 ubiquitin ligase to modulate cell cycle.
    Hrecka K; Gierszewska M; Srivastava S; Kozaczkiewicz L; Swanson SK; Florens L; Washburn MP; Skowronski J
    Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11778-83. PubMed ID: 17609381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 Vpr induces the K48-linked polyubiquitination and proteasomal degradation of target cellular proteins to activate ATR and promote G2 arrest.
    Belzile JP; Richard J; Rougeau N; Xiao Y; Cohen EA
    J Virol; 2010 Apr; 84(7):3320-30. PubMed ID: 20089662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VprBP/DCAF1 regulates p53 function and stability through site-specific phosphorylation.
    Ghate NB; Kim S; Mehmood R; Shin Y; Kim K; An W
    Oncogene; 2023 Apr; 42(17):1405-1416. PubMed ID: 37041410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIPK2 modulates p53 activity towards pro-apoptotic transcription.
    Puca R; Nardinocchi L; Sacchi A; Rechavi G; Givol D; D'Orazi G
    Mol Cancer; 2009 Oct; 8():85. PubMed ID: 19828042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetylation-regulated interaction between p53 and SET reveals a widespread regulatory mode.
    Wang D; Kon N; Lasso G; Jiang L; Leng W; Zhu WG; Qin J; Honig B; Gu W
    Nature; 2016 Oct; 538(7623):118-122. PubMed ID: 27626385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 Vpr induces the degradation of ZIP and sZIP, adaptors of the NuRD chromatin remodeling complex, by hijacking DCAF1/VprBP.
    Maudet C; Sourisce A; Dragin L; Lahouassa H; Rain JC; Bouaziz S; Ramirez BC; Margottin-Goguet F
    PLoS One; 2013; 8(10):e77320. PubMed ID: 24116224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoplasmic retention of HIV-1 regulatory protein Vpr by protein-protein interaction with a novel human cytoplasmic protein VprBP.
    Zhang S; Feng Y; Narayan O; Zhao LJ
    Gene; 2001 Jan; 263(1-2):131-40. PubMed ID: 11223251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular insight into how HIV-1 Vpr protein impairs cell growth through two genetically distinct pathways.
    Maudet C; Bertrand M; Le Rouzic E; Lahouassa H; Ayinde D; Nisole S; Goujon C; Cimarelli A; Margottin-Goguet F; Transy C
    J Biol Chem; 2011 Jul; 286(27):23742-52. PubMed ID: 21566118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VPRBP Functions Downstream of the Androgen Receptor and OGT to Restrict p53 Activation in Prostate Cancer.
    Poulose N; Forsythe N; Polonski A; Gregg G; Maguire S; Fuchs M; Minner S; Sauter G; McDade SS; Mills IG
    Mol Cancer Res; 2022 Jul; 20(7):1047-1060. PubMed ID: 35348747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HIV-1 accessory protein Vpr induces the degradation of the anti-HIV-1 agent APOBEC3G through a VprBP-mediated proteasomal pathway.
    Zhou D; Wang Y; Tokunaga K; Huang F; Sun B; Yang R
    Virus Res; 2015 Jan; 195():25-34. PubMed ID: 25200749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.